KYAT1
KYAT1| KYAT1 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||
| 식별자 | |||||||||||||||||||||||||
| 에일리어스 | KYAT1, GTK, KAT1, KATI, CCBL1, 키뉴레닌아미노전달효소1 | ||||||||||||||||||||||||
| 외부 ID | OMIM: 600547 MGI: 1917516 HomoloGene: 37872 GenCard: KYAT1 | ||||||||||||||||||||||||
| EC 번호 | 4.4.1.13 | ||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| 맞춤법 | |||||||||||||||||||||||||
| 종. | 인간 | 마우스 | |||||||||||||||||||||||
| 엔트레즈 | |||||||||||||||||||||||||
| 앙상블 | |||||||||||||||||||||||||
| 유니프로트 | |||||||||||||||||||||||||
| RefSeq(mRNA) | |||||||||||||||||||||||||
| RefSeq(단백질) |
| ||||||||||||||||||||||||
| 장소(UCSC) | 없음 | Chr 2: 30.08 ~30.1 Mb | |||||||||||||||||||||||
| PubMed 검색 | [2] | [3] | |||||||||||||||||||||||
| 위키데이터 | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
키뉴레닌-옥소글루타르산트랜스아미나아제1은 CCBL1 유전자에 [4][5]의해 인체에서 암호화되는 효소이다.키뉴레나인 옥소글루타르산 트랜스아미나아제 중 하나입니다.
이 유전자는 특정 할로겐화 알케인과 알칸의 시스테인 결합체의 대사를 담당하는 세포질 효소를 암호화한다.이 신진대사는 신독성 [5]및 신경독성으로 이어질 수 있는 반응성 대사물의 형성을 이끈다.
레퍼런스
- ^ a b c GRCm38: 앙상블 릴리즈 89: ENSMUSG000039648 - 앙상블, 2017년 5월
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Perry S, Harries H, Scholfield C, Lock T, King L, Gibson G, Goldfarb P (Apr 1995). "Molecular cloning and expression of a cDNA for human kidney cysteine conjugate beta-lyase". FEBS Lett. 360 (3): 277–80. doi:10.1016/0014-5793(95)00123-Q. PMID 7883047. S2CID 83606450.
- ^ a b "Entrez Gene: CCBL1 cysteine conjugate-beta lyase; cytoplasmic (glutamine transaminase K, kyneurenine aminotransferase)".
외부 링크
- UCSC Genome Browser의 인간 CCBL1 게놈 위치 및 CCBL1 유전자 상세 페이지.
추가 정보
- Cooper AJ (2004). "The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants". Neurochem. Int. 44 (8): 557–77. doi:10.1016/j.neuint.2003.12.002. PMID 15016471. S2CID 7643547.
- Lash LH, Nelson RM, Van Dyke RA, Anders MW (1990). "Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity". Drug Metab. Dispos. 18 (1): 50–4. PMID 2139845.
- Abraham DG, Patel PP, Cooper AJ (1995). "Isolation from rat kidney of a cytosolic high molecular weight cysteine-S-conjugate beta-lyase with activity toward leukotriene E4". J. Biol. Chem. 270 (1): 180–8. doi:10.1074/jbc.270.1.180. PMID 7814371.
- Goldfarb P, Perry S, Harries H, et al. (1996). "Molecular cloning and expression of cDNAs for rat and human kidney cysteine conjugate beta-lyase". Biochem. Soc. Trans. 24 (2): 330S. doi:10.1042/bst024330s. PMID 8736988.
- Iyer RA, Anders MW (1997). "Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria". Anesthesiology. 85 (6): 1454–61. doi:10.1097/00000542-199612000-00028. PMID 8968194. S2CID 39394531.
- Gilley J, Fried M (1999). "Extensive gene order differences within regions of conserved synteny between the Fugu and human genomes: implications for chromosomal evolution and the cloning of disease genes". Hum. Mol. Genet. 8 (7): 1313–20. doi:10.1093/hmg/8.7.1313. PMID 10369878.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). "DNA sequence and analysis of human chromosome 9". Nature. 429 (6990): 369–74. Bibcode:2004Natur.429..369H. doi:10.1038/nature02465. PMC 2734081. PMID 15164053.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
- Kapoor R, Lim KS, Cheng A, et al. (2006). "Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)". Brain Res. 1106 (1): 205–10. doi:10.1016/j.brainres.2006.05.082. PMID 16828464. S2CID 42325649.